Find Tecarfarin manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 867257-26-9, Ati-5923, 1,1,1,3,3,3-hexafluoro-2-methylpropan-2-yl 4-((4-hydroxy-2-oxo-2h-chromen-3-yl)methyl)benzoate, Wn1479yt50, 1,1,1,3,3,3-hexafluoro-2-methylpropan-2-yl 4-[(4-hydroxy-2-oxo-2h-chromen-3-yl)methyl]benzoate, Benzoic acid, 4-((4-hydroxy-2-oxo-2h-1-benzopyran-3-yl)methyl)-, 2,2,2-trifluoro-1-methyl-1-(trifluoromethyl)ethyl ester
Molecular Formula
C21H14F6O5
Molecular Weight
460.3  g/mol
InChI Key
QFLNTQDOVCLQKW-UHFFFAOYSA-N
FDA UNII
WN1479YT50

Tecarfarin
Tecarfarin has been used in trials studying the prevention of Thrombosis and Thromboembolism.
1 2D Structure

Tecarfarin

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(1,1,1,3,3,3-hexafluoro-2-methylpropan-2-yl) 4-[(4-hydroxy-2-oxochromen-3-yl)methyl]benzoate
2.1.2 InChI
InChI=1S/C21H14F6O5/c1-19(20(22,23)24,21(25,26)27)32-17(29)12-8-6-11(7-9-12)10-14-16(28)13-4-2-3-5-15(13)31-18(14)30/h2-9,28H,10H2,1H3
2.1.3 InChI Key
QFLNTQDOVCLQKW-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC(C(F)(F)F)(C(F)(F)F)OC(=O)C1=CC=C(C=C1)CC2=C(C3=CC=CC=C3OC2=O)O
2.2 Other Identifiers
2.2.1 UNII
WN1479YT50
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 1,1,1,3,3,3-hexafluoro-2-methylpropan-2-yl 4-((4-hydroxy-2-oxo-2h-1-benzopyran-3-yl)methyl)benzoate

2. Ati 5923

3. Ati-5923

4. Ati5923

2.3.2 Depositor-Supplied Synonyms

1. 867257-26-9

2. Ati-5923

3. 1,1,1,3,3,3-hexafluoro-2-methylpropan-2-yl 4-((4-hydroxy-2-oxo-2h-chromen-3-yl)methyl)benzoate

4. Wn1479yt50

5. 1,1,1,3,3,3-hexafluoro-2-methylpropan-2-yl 4-[(4-hydroxy-2-oxo-2h-chromen-3-yl)methyl]benzoate

6. Benzoic Acid, 4-((4-hydroxy-2-oxo-2h-1-benzopyran-3-yl)methyl)-, 2,2,2-trifluoro-1-methyl-1-(trifluoromethyl)ethyl Ester

7. Tecarfarin [usan]

8. Tecarfarin [usan:inn]

9. Unii-wn1479yt50

10. Tecarfarin [inn]

11. Tecarfarin (usan/inn)

12. Tecarfarin [who-dd]

13. Schembl1647984

14. Chembl2105664

15. Ati5923

16. Dtxsid90235788

17. Ati 5923

18. Bcp31892

19. Db12823

20. Sb18978

21. (1,1,1,3,3,3-hexafluoro-2-methylpropan-2-yl) 4-[(4-hydroxy-2-oxochromen-3-yl)methyl]benzoate

22. Hy-14854

23. Cs-0003597

24. D09676

25. Ati-5923; Ati 5923; Ati5923

26. 257h269

27. Q27292724

28. 1,1,1,3,3,3-hexafluoro-2-methylpropan-2-yl4-((4-hydroxy-2-oxo-2h-chromen-3-yl)methyl)benzoate

29. 2,2,2-trifluoro-1-methyl-1-(trifluoromethyl)ethyl 4-((4-hydroxy-2-oxo-2h-1-benzopyran-3-yl)methyl)benzoate

30. 2,2,2-trifluoro-1-methyl-1-(trifluoromethyl)ethyl 4-((4-hydroxy-2-oxo-2h-chromen-3-yl)methyl)benzoate

31. Benzoic Acid, 4-[(4-hydroxy-2-oxo-2h-1-benzopyran-3-yl)methyl]-, 2,2,2-trifluoro-1-methyl-1-(trifluoromethyl)ethyl?ester

2.4 Create Date
2011-12-26
3 Chemical and Physical Properties
Molecular Weight 460.3 g/mol
Molecular Formula C21H14F6O5
XLogP35.5
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count11
Rotatable Bond Count5
Exact Mass460.07454252 g/mol
Monoisotopic Mass460.07454252 g/mol
Topological Polar Surface Area72.8 Ų
Heavy Atom Count32
Formal Charge0
Complexity750
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty